HopeStage
Study directory

Depression studies

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

Back to overview
More filters: keywords, city, remote
7264studies shown
Showing 265-276 of 7,264
Drug study icon
RecruitingACTRN12610001011077

Rapid depression treatment in cancer patients

Official study title

Effects of low dose intramuscular ketamine on depression ratings in depressed patients with cancer in palliative care

In New Zealand
DepressionInterventional studyAges 20–65
Countries
New Zealand
Sponsor
University of Otago
Drug study icon
Not Yet RecruitingACTRN12626000909325

Single-arm Basket study of Intravenously Administered Psilocin (TRP-8803) in Eating disorders, Fibromyalgia, Generalised Anxiety Disorder, Irritable Bowel Syndrome, OCD, PTSD, and Treatment-resistant Major Depressive Disorder

Official study title

A Phase 1, Open-label, Single-arm Basket Trial of Intravenously Administered Psilocin (TRP-8803) in Anorexia Nervosa, Fibromyalgia, Generalised Anxiety Disorder, Irritable Bowel Syndrome, Obsessive Compulsive Disorder, Post Traumatic Stress Disorder, and Treatment-resistant Major Depressive Disorder

This study isn't recruiting yet.

In Australia
Depression, PTSD, ...Interventional studyAges 18–60
Countries
Australia
Sponsor
Tryptamine Therapeutics
Drug study icon
RecruitingNCT07412756

Brenipatide in adults with Major Depressive Disorder

What is this study about?

This study evaluates the safety and effectiveness of Brenipatide for people with depression.

Multiple locations, including Moorpark
DepressionMedication studyAges 18–75
Countries
United States, Australia, Canada, + 11 others
Sponsor
Eli Lilly and Company
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.